Ovarian Cancer Patients Survive Longer With BRCA2 Mutated In Tumors
10/12/2011
Women with high-grade ovarian cancer live longer and respond better to platinum-based chemotherapy when their tumors have BRCA2 genetic mutations, researchers at The University of Texas MD Anderson Cancer Center and the Institute for Systems Biology report in the Oct. 12 issue of the Journal of the American Medical Association...
Ginger Root Supplement Reduced Colon Inflammation Markers
10/12/2011
Ginger supplements reduced markers of colon inflammation in a select group of patients, suggesting that this supplement may have potential as a colon cancer prevention agent, according to a study published in Cancer Prevention Research, a journal of the American Association for Cancer Research. Suzanna M. Zick, N.D., M.P.H...
Researchers Develop New Way To Screen For Brain Cancer Stem Cell Killers
10/12/2011
Researchers with UCLA's Jonsson Comprehensive Cancer Center have developed and used a high-throughput molecular screening approach that identifies and characterizes chemical compounds that can target the stem cells that are responsible for creating deadly brain tumors. Glioblastoma is one of the deadliest malignancies, typically killing patients within 12 to 18 months...
Leukemia Drug Sprycel (Dasatinib) Has Risk Of Pulmonary Arterial Hypertension, Warns FDA
10/12/2011
Sprycel (dasatinib), a leukemia medication raises the risk of developing pulmonary arterial hypertension, the US Food and Drug Administration (FDA) announced today in a Drug Safety Communication. The FDA says doctors should check patients for signs and symptoms of underlying cardiopulmonary disease before considering prescribing Sprycel - they should also evaluate patients during treatment...
Leukemia Drug Sprycel (Dasatinib) Has Risk Of Pulmonary Arterial Hypertension, Warns FDA
10/11/2011
Sprycel (dasatinib), a leukemia medication raises the risk of developing pulmonary arterial hypertension, the US Food and Drug Administration (FDA) announced today in a Drug Safety Communication. The FDA says doctors should check patients for signs and symptoms of underlying cardiopulmonary disease before considering prescribing Sprycel - they should also evaluate patients during treatment...
Chronic Lymphocytic Leukemia Patients' Lives Extended By New Combination Treatment
10/11/2011
According to an investigation published Online First in The Lancet Oncology, for individuals who have relapsed with the most prevalent type of leukemia, chronic lymphocytic leukemia (CLL), a novel, less toxic, treatment that combines the chemotherapy drug fludarabine and the monoclonal antibody alemtuzumab, considerably increases progression free survival (PFS) and extends the ...
Chronic Lymphocytic Leukemia Patients' Lives Extended By New Combination Treatment
10/11/2011
According to an investigation published Online First in The Lancet Oncology, for individuals who have relapsed with the most prevalent type of leukemia, chronic lymphocytic leukemia (CLL), a novel, less toxic, treatment that combines the chemotherapy drug fludarabine and the monoclonal antibody alemtuzumab, considerably increases progression free survival (PFS) and extends the ...
Tanning Beds Minimum Age Raised To 18 In California
10/11/2011
The youngest legal age for using tanning beds has gone up from 14 to 18 years in California after Governor Jerry Brown signed a new bill into law. Beforehand, those aged between 14 and 18 were allowed to use tanning salon services if they had permission from their parents - not any more...
Tanning Beds Minimum Age Raised To 18 In California
10/11/2011
The youngest legal age for using tanning beds has gone up from 14 to 18 years in California after Governor Jerry Brown signed a new bill into law. Beforehand, those aged between 14 and 18 were allowed to use tanning salon services if they had permission from their parents - not any more...
Potential Biologic Therapies That Specifically Target Metastasis
10/11/2011
Researchers at the Medical College of Wisconsin have shown that a protein can inhibit metastasis of colon and melanoma cancers. The findings are published in the October 10, 2011 issue of Proceedings of the National Academy of Sciences. Michael B. Dwinell, Ph.D...